Beauchamp, T. L. (2003) Methods and principles in biomedical ethics. Journal of Medical Ethics, 29, 269–274.
Bock, N. N., Sales, R. M., Rogers, T., et al (2001) A spoonful of sugar … improving adherence to tuberculosis treatment using financial incentives. International Journal of Tuberculosis and Lung Disease, 5, 96–98.
Carey, K. B. & Carey, M. P. (1990) Enhancing the treatment attendance of mentally ill chemical abusers. Journal of Behavior Therapy and Experimental Psychiatry, 21, 205–209.
Cogswell, S. H. (2004) Entitlements, payees and coercion. In Coercion and Aggressive Community Treatment: A New Frontier in Mental Health Law. (eds Dennis-Deborah, L. & Monahan, J.), pp.115–125. Plenum Press.
Elbogen, E. B., Soriano, C., Dorn, R.V., et al (2005) Consumer views of representative payee use of disability funds to leverage treatment adherence. Psychiatric Services, 56, 45–49.
Giuffrida, A. & Torgerson, D. J. (1997) Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ, 315, 703–707.
Leucht, S., Barnes, T. R., Kissling, W., et al (2003) Relapse prevention in schizophrenia with new-generation antipsychotics: asystematic review and exploratory meta-analysis of randomized, controlled trials. American Journal of Psychiatry, 160, 1209–1222.
Longman (2003) Dictionary of Contemporary English. Pearson Education.
McDonald, H. P., Garg, A. X. & Haynes, R. B. (2002) Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA, 288, 2868–2879.
Monahan, J., Bonnie, R. J., Appelbaum, P. S., et al (2001) Mandated community treatment: beyond outpatient commitment. Psychiatric Services, 52, 1198–1205.
Monahan, J., Redlich, A. D., Swanson, J., et al (2005) Use of leverage to improve adherence to psychiatric treatment in the community. Psychiatric Services, 56, 37–44.
Nose, M., Barbui, C., Gray, R., et al (2003) Clinical interventions for treatment non-adherence in psychosis: meta-analysis. British Journal of Psychiatry, 183, 197–206.
O'Donnell, C., Donohoe, G., Sharkey, L., et al (2003) Compliance therapy: a randomised controlled trial in schizophrenia. BMJ, 327, 834.
Pereira, S., Beer, D. & Paton, C. (1999) Enforcing treatment with clozapine: survey of views and practice. Psychiatric Bulletin, 23, 342–345.
Priebe, S., Fakhoury, W., Watts, J., et al (2003) Assertive outreach teams in London: patient characteristics and outcomes. Pan-London Assertive Outreach Study, part 3. British Journal of Psychiatry, 183, 148–154.
Roberts, L.W. & Geppert, C. M. (2004) Ethical use of long-acting medications in the treatment of severe and persistent mental illnesses. Comprehensive Psychiatry, 45, 161–167.
Roberts, L. W., Warner, T. D., Nguyen, K. P., et al (2003) Schizophrenia patients' and psychiatrists' perspectives on ethical aspects of symptom re-emergence during psychopharmacological research participation. Psychopharmacology (Berlin), 171, 58–67.
Swartz, M. S. & Monahan, J. (2001) Special section on involuntary outpatient commitment: introduction. Psychiatric Services, 52, 323–324.
Tulsky, J. P., Hahn, J. A., Long, H. L., et al (2004) Can the poor adhere? Incentives for adherence to TB prevention in homeless adults. International Journal of Tuberculosis and Lung Disease, 8, 83–91.
Watts, J. & Priebe, S. (2002) A phenomenological account of users' experiences of assertive community treatment. Bioethics, 16, 439–454.
Weaver, T., Tyrer, P., Ritchie, J., et al (2003) Assessing the value of assertive outreach. Qualitative study of process and outcome generation in the UK700 trial. British Journal of Psychiatry, 183, 437–445.
Wertheimer, A. (1993) A philosophical examination of coercion for mental health issues. Behavioural Sciences and the Law, 11, 239–258.
Williamson, T. (2002) Ethics of assertive outreach (assertive community treatment teams). Current Opinion in Psychiatry, 15, 543–547.
World Health Organization (1992) The ICD–10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines.